--- title: "Pre-market hot trades in US stocks: TMD Energy pre-market down 8.05%; Zhongchao pre-market down 7.95%" type: "News" locale: "en" url: "https://longbridge.com/en/news/292622462.md" description: "TMD Energy pre-market down 8.05%; Zhongchao pre-market down 7.95%; NextCure pre-market up 312.84%; Shuttle Pharmaceuticals pre-market up 70.61%; Vision Marine Tech pre-market up 39.73%" datetime: "2026-07-14T12:07:51.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292622462.md) - [en](https://longbridge.com/en/news/292622462.md) - [zh-HK](https://longbridge.com/zh-HK/news/292622462.md) --- # Pre-market hot trades in US stocks: TMD Energy pre-market down 8.05%; Zhongchao pre-market down 7.95% **Pre-market Hot Trades in US Stocks** TMD Energy is down 8.05% in pre-market trading. Based on recent news, 1. On July 14, TMD Energy's trust fund is nearing liquidation and delisting, with traditional income assets gradually disappearing. Investor concerns over geopolitical and inflation risks have increased, leading to a decline in stock prices. 2. On July 13, the market is filled with uncertainty regarding the upcoming Q2 2026 earnings season, and investors are taking a wait-and-see approach to TMD Energy's future performance, further exacerbating stock price volatility. 3. On July 12, TMD Energy faces challenges in a tightening financing environment, with market doubts about whether its operational adjustments are temporary measures or a permanent strategic shift, putting pressure on stock prices. Concerns over geopolitical and inflation risks have increased. Zhongchao is down 7.95% in pre-market trading, with no significant news recently. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. **Top Gainers in Pre-market US Stocks** NextCure is up 312.84% in pre-market trading. Based on recent news, 1. On July 14, NextCure announced it will merge with Avere Therapeutics and will operate under the Avere Therapeutics name. This news significantly boosted NextCure's stock price. After the merger, Avere shareholders will hold approximately 98.8% of the merged company, while NextCure shareholders will hold only about 1.2%. 2. On July 14, NextCure announced it has secured $320 million in private financing to develop AVR-001, an experimental weekly pill for inflammatory diseases. This financing news further boosted market confidence, driving up the stock price. 3. On July 14, Hansoh Pharmaceutical announced it has signed an exclusive licensing agreement with Avere, granting Avere exclusive rights to develop, manufacture, and commercialize AVR-001 globally (excluding mainland China, Hong Kong, Macau, and Taiwan). This news further enhances market confidence in the merged company. The biotechnology sector has been active recently, with significant capital inflows. Shuttle Pharmaceuticals is up 70.61% in pre-market trading. Based on recent key news: 1. On July 13, HRT Financial LP increased its direct holdings in Shuttle Pharmaceuticals, purchasing 8,997 shares at prices between $3.11 and $3.38. This move shows market confidence in the company, significantly boosting the stock price. Source: EDGAR system disclosure. 2. On July 13, HRT Financial reported a 10% stake in Shuttle Pharmaceuticals in Form 3, indicating it held 60,540 shares of common stock as of July 9 This shareholding information further enhances investors' expectations for the company's future development, leading to a rise in stock prices. Source: The EDGAR system discloses that recent fluctuations in the U.S. stock market have intensified, and investors should exercise caution. Vision Marine Tech pre-market rose by 39.73%. Based on recent key news: 1. On July 13, Vision Marine Technologies released the latest documents on the EDGAR system, showing progress in technology development and commercialization, driving up the stock price. Source: EDGAR 2. On July 9, HRT Financial sold its remaining shares of Vision Marine Technologies. Although the stock price faced short-term pressure, the market remains optimistic about the company's future development. Source: EDGAR 3. Recently, Vision Marine has faced supply chain disruptions and competitive pressures, but the company has made progress in qualifying alternative battery suppliers, boosting investor confidence. Source: EDGAR Supply chain disruptions and competitive pressures affect market sentiment ### Related Stocks - [TMDE.US](https://longbridge.com/en/quote/TMDE.US.md) - [ZCMD.US](https://longbridge.com/en/quote/ZCMD.US.md) - [NXTC.US](https://longbridge.com/en/quote/NXTC.US.md) - [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md) - [VMAR.US](https://longbridge.com/en/quote/VMAR.US.md) ## Related News & Research - [1ST Source Bank Makes New $1 Million Investment in Kimberly-Clark Corporation $KMB](https://longbridge.com/en/news/296066722.md) - [GOOGL Stock Alert: Google Unleashes Its Biggest Weapon Against Apple](https://longbridge.com/en/news/295964022.md) - [Mitsubishi UFJ Trust & Banking Corp Buys 54,637 Shares of ConocoPhillips $COP](https://longbridge.com/en/news/296084237.md) - [Kinder Morgan, Inc. $KMI Shares Sold by Mitsubishi UFJ Trust & Banking Corp](https://longbridge.com/en/news/296084298.md) - [ABN AMRO Bank N.V. Buys New Shares in Ecolab Inc. $ECL](https://longbridge.com/en/news/296015276.md)